Translational medicine is central to the goal of converting basic discoveries to diagnostic and therapeutic tools that can be harnessed to treat disease and improve human health.
So how do the dancers choose who to invite to the dance floor in the first place? What makes a startup appealing to an investor, and what makes an investor attractive to the investee?
The time has come when our dramatically increased knowledge of the human immune system is finally being exploited into novel exciting therapies in various diseases.
Translational medicine is central to the goal of converting basic discoveries to diagnostic and therapeutic tools that can be harnessed to treat diseases and improve human health.
Translational medicine can be defined as the continuum from a scientific idea or finding to a diagnostic tool and/or therapy applied to human diseases.
This year, Nature SciCafe Asia 2017 partnered with Singapore Quickfire Challenge – Metabolic Disease Innovation, to present Ecosystem Day at SWITCH 2017, as we touch on the theme of ‘Creation of Ecosystems in Biosciences’.
This year, we explored on ‘How policies drive innovation in BioMedicine’ – hearing views from the Pharmaceutical industry, government representatives from around the APAC region and venture capitalists.
August 24th, 2016 in Duke-NUS Medical School, Singapore
October 21st, 2015 in Duke-NUS Medical School, Singapore